Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury
about
Function, structure and therapeutic potential of complement C5a receptorsThe complement system and adverse pregnancy outcomesComplement inhibition promotes endogenous neurogenesis and sustained anti-inflammatory neuroprotection following reperfused strokeNeutrophil Depletion Attenuates Placental Ischemia-Induced Hypertension in the RatC3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathwayTargeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.Role of the complement components C5 and C3a in a mouse model of myocardial ischemia and reperfusion injury.Differential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant rats.Downsizing a human inflammatory protein to a small molecule with equal potency and functionality.Elimination of C5aR prevents intestinal mucosal damage and attenuates neutrophil infiltration in local and remote organs.New insights of an old defense system: structure, function, and clinical relevance of the complement system.Increased Susceptibility of Humanized NSG Mice to Panton-Valentine Leukocidin and Staphylococcus aureus Skin Infection.Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock.Novel C5a regulators in inflammatory disease.C3a and C5a promote renal ischemia-reperfusion injury.The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization.Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.C3a receptor deficiency accelerates the onset of renal injury in the MRL/lpr mouse.Association of immune and metabolic receptors C5aR and C5L2 with adiposity in women.Role of complement and perspectives for intervention in ischemia-reperfusion damage.Complement activation in the injured central nervous system: another dual-edged sword?Tumor necrosis-initiated complement activation stimulates proliferation of medulloblastoma cells.From apelin to exercise: emerging therapies for management of hypertension in pregnancy.Improved yield and functional parameters of rat pancreas islets isolated under intramuscular anesthesia.A Commentary On: "NFκB-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer's Disease". A cautionary note regarding C3aR.Complement anaphylatoxins C3a and C5a induce a failing regenerative program in cardiac resident cells. Evidence of a role for cardiac resident stem cells other than cardiomyocyte renewal.Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3aC3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent.The Complement System and Preeclampsia.Beneficial effects of Houttuynia cordata polysaccharides on "two-hit" acute lung injury and endotoxic fever in rats associated with anti-complementary activities.C3a triggers formation of sub-retinal pigment epithelium deposits via the ubiquitin proteasome pathway.CD177-mediated nanoparticle targeting of human and mouse neutrophilsLPS preconditioning ameliorates intestinal injury in a rat model of hemorrhagic shockInternalization of staphylococcal leukotoxins that bind and divert the C5a receptor is required for intracellular Ca2+mobilization by human neutrophils
P2860
Q24669712-56CEBF4D-4AE3-4648-8D58-BE5CC9E1CA43Q26863600-2D5C78C9-062D-434A-9149-E88ECC817E7DQ27301338-FB37D31F-584B-4D80-A9D3-E7C492C66F9FQ27303128-8EF60073-91C3-4F6F-9E1A-BDE63DA90535Q28545168-D365F757-D603-4E93-B47E-6E64F143A9E4Q33925353-D5AAE424-CD7E-49FC-ABC5-8B7EB0AA7F77Q34131214-4FEB787B-40E3-4167-A7FC-35E875A03CE9Q34360684-48611F96-A517-4EB1-834A-5A31B8E4CDEDQ34386483-48B6B585-79F4-42E5-BB48-1ABF599C769BQ34509114-1858A6EE-F662-4436-B0A8-6B65081737A4Q34699496-AC0FFE0B-7D49-446A-AC9B-D0657FB7F41AQ35855538-91716DED-6F98-4E60-BB4C-9543E947CAB4Q35882816-E39F27A8-7124-4E1C-B0C2-C1552EAEDC1DQ36196446-6182425C-C3FD-406D-862E-9B8446CDA5FAQ36200905-83C46E59-EAE0-418A-A2DA-B2B36AB64EE7Q36915584-BA3B7BD6-DC24-44B2-84DF-BB8F624D6453Q37091310-AB74DBF1-8565-445C-960B-963C8C14AAFCQ37230515-82509C97-A110-45B0-9DA3-7078272F96B5Q37553814-0DC7BC26-A2DD-4946-A0C5-83F5B9904A2CQ37831329-DE088101-8F0E-4A79-A202-BB35D77D0456Q38020570-D12BAC4B-6E5C-4D1D-B364-38BE3CE2638BQ38918352-AFEA9881-F844-4447-BA9C-35927623A6D2Q39223093-A0DC817A-ECC4-47C6-93C9-D83AC03D252BQ39689069-6A1FDD2F-BAB5-415B-BDEF-B5E71F6A510AQ40390894-FCC29761-65A0-4C59-9751-3B0B0CAE9DB8Q41379852-39E7C71C-C48D-4F39-8C9D-7D0CA338D69BQ41516139-AF03B3AE-3D3E-4792-9A76-C2AE0888E3BFQ46807095-ABB7D74E-854E-4F1D-9F49-02AB8DCD1E43Q47889401-D610D590-D341-4C4F-B2BF-EAE9FBA4A890Q55399408-68065BAB-5609-457E-A565-47A06E786D56Q55426544-A466E34C-65BD-4A09-A51F-2391C2CE7EB5Q56888986-0378681D-DDDA-4A24-B142-A0EC5006DD90Q57109740-C5D22B3D-C690-4649-9255-18684635985FQ57823983-59DDA4F1-72A0-4A27-BFC1-6B05DDFE48CC
P2860
Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Comparative anti-inflammatory ...... l ischaemia/reperfusion injury
@en
type
label
Comparative anti-inflammatory ...... l ischaemia/reperfusion injury
@en
prefLabel
Comparative anti-inflammatory ...... l ischaemia/reperfusion injury
@en
P2093
P2860
P356
P1476
Comparative anti-inflammatory ...... l ischaemia/reperfusion injury
@en
P2093
Ian Shiels
Lavinia M Proctor
Stephen M Taylor
Thiruma V Arumugam
P2860
P304
P356
10.1038/SJ.BJP.0705819
P407
P577
2004-05-24T00:00:00Z